Patents by Inventor Stéfan Jonathan HALBHERR

Stéfan Jonathan HALBHERR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIPOSOMAL COMPOSITION FOR USE IN A METHOD OF TREATING PARKINSON'S DISEASE
    Publication number: 20230210875
    Abstract: A method of treating Parkinson's disease in a subject in need thereof. The method comprises administering a liposomal composition, comprising sphingomyelin in a lipid bilayer and a therapeutically effective amount of GM1, to the subject.
    Type: Application
    Filed: March 9, 2023
    Publication date: July 6, 2023
    Inventors: Stéfan Jonathan HALBHERR, Camille Françoise PEITSCH
  • IMMUNOGENIC COMPOSITION COMPRISING AN ANTIGENIC MOIETY AND A LIPOSOMAL FORMULATION, METHOD OF PRODUCING THE COMPOSITION, THE COMPOSITION FOR USE AS A MEDICAMENT, IN PARTICULAR FOR USE AS A VACCINE
    Publication number: 20230181711
    Abstract: The present invention concerns an immunogenic composition comprising (a) an antigenic moiety, preferably an antigenic moiety being or comprising an amino acid sequence corresponding to a surface protein domain of SARS-CoV-2 virus; and (b) a liposomal formulation as an adjuvant. More specifically, the antigenic moiety preferably is either the receptor binding domain RBD of Spike protein S of SARS-CoV-2 virus, or the HR domain of S2 subunit of spike protein S of SARS-CoV-2 virus; or an immunogenic fragment thereof. The invention further relates to a method of producing an immunogenic composition and the use of such composition as a medicament.
    Type: Application
    Filed: April 7, 2021
    Publication date: June 15, 2023
    Inventors: Stéfan Jonathan HALBHERR, Camille PEITSCH, Diego VON WERDT
  • Liposomes comprising sphingomyelin
    Patent number: 11607385
    Abstract: Liposomes which comprise sphingomyelin in the lipid bilayer. The liposomes are configured to cross the blood-brain barrier for the treatment of neuro-degenerative diseases and spinal cord injuries. The liposomes are essentially free of ganglioside. A method of producing liposomes is also disclosed along with use of liposome as a medicament.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: March 21, 2023
    Assignee: INNOMEDICA HOLDING AG
    Inventors: Stéfan Jonathan Halbherr, Camille Peitsch
  • LIPOSOMAL DOXORUBICIN FORMULATION, METHOD FOR PRODUCING A LIPOSOMAL DOXORUBICIN FORMULATION AND USE OF A LIPOSOMAL DOXORUBICIN FORMULATION AS A MEDICAMENT
    Publication number: 20220265556
    Abstract: The present invention relates to a liposomal doxorubicin formulation, a method for producing a liposomal doxorubicin formulation and a liposomal doxorubicin formulation for use as a medicament, in particular for use in the treatment of cancer, uterine leiomyosarcoma and adnexal skin cancer.
    Type: Application
    Filed: June 19, 2020
    Publication date: August 25, 2022
    Inventors: Stéfan Jonathan HALBHERR, Pascal HALBHERR, Christoph MATHIEU, Patrick BUSCHOR
  • LIPOSOMES COMPRISING SPHINGOMYELIN
    Publication number: 20210077398
    Abstract: Liposomes which comprise sphingomyelin in the lipid bilayer. The liposomes are configured to cross the blood-brain barrier for the treatment of neuro-degenerative diseases and spinal cord injuries. The liposomes are essentially free of ganglioside. A method of producing liposomes is also disclosed along with use of liposome as a medicament.
    Type: Application
    Filed: December 20, 2018
    Publication date: March 18, 2021
    Inventor: Stéfan Jonathan HALBHERR